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Introduction
Haemophilus parasuis (H. parasuis), is the causative agent of the Glässer's disease in swine with phenotypic presentation of polyserositis, meningitis and arthritis (Oliveira and Pijoan 2004) . In recent years it has become one of the most important respiratory bacterial pathogens of livestock worldwide and can cause gross economic losses (Rapp-Gabrielson et al. 1997) . To date, fifteen serovars of H. parasuis have been identified, however, up to 20% isolates could not be sero-typed in some countries (Kielstein and Rapp-Gabrielson 1992) . Serovar 4 and serovar 5 are the most frequently detected in most countries (Rúbies et al. 1999; Cai et al. 2005) . Although vaccine immunization is thought to be the best method to control and prevent infectious disease (Rappuoli et al. 2002) , currently no good vaccine is available which can provide protection against the challenge of all serovars of pathogenic H. parasuis.
The pathogenesis of H. parasuis infection is poorly understood -only a few number of virulence -related factors have been linked to the pathogenicity of Glässer's disease. ClpP plays an essential role in stress tolerance, and negatively regulates biofilm formation by H. parasuis (Huang et al. 2016) . cheY plays a crucial role in growth, colonization, biofilm formation and autoagglutination of H. parasuis (He et al. 2016) . Deletion of rfaE gene can attenuate resistance, adhesiom and invasion of H. parasuis to PUVEC and PK-15 cells (Zhang et al. 2014) . capD gene is a novel pathogenicity-associated determinant and involves in serum-resistance ability of H. parasuis (Wang et al. 2013) . Previous reports demonstrated that immunization against virulence -related proteins, which mostly were outer membrane proteins D r a f t (OMPs) , could confer protection against the infection of microbe (Tavares er al. 2003; Vilanova et al. 2004) . Importantly, some protective or immunogenic antigens have been identified that potentially can be used as vaccine candidates, for example, Omp26, VacJ, HAPS-0742 (Li et al. 2016) , PflA, Gcp, Ndk, HsdS, RnfC, HAPS-0017 (Li et al. 2015) , TbpB (Frandoloso et al. 2015) , rGAPDH, rOapA, rHPS-0675 (Fu et al. 2013a ) and 6PGD (Fu et al. 2012a) . Even though some potential vaccine candidates have been studied, the mechanism of immune protection triggered by vaccines is poorly understood.
The genomic sequencing of H. parasuis SH0165 strain has been completed (Yue et al. 2009 ). We have found superoxide dismutase (SOD) gene present in H. parasuis genome. SOD is a family of antioxidant enzymes that function as a frontline defense against superoxide anion radicals ( . O2 -) which were produced in all aerobic cells (Fridovich 1998) . It has been documented that SOD is very useful to treat systemic inflammatory diseases (Shafey et al. 2010 ). To date, using H. parasuis SOD protein as a vaccine candidate has not been reported previously.
In this study, we constructed an experimental H. parasuis SOD vaccine and determined the protective efficacy of the H. parasuis SOD using a lethal dose challenge of H. parasuis serovar 4 and serovar 5 in a mouse model.
Materials and methods

Bacteria strains and growth conditions
H. parasuis (serovar 4, strain MD0322; serovar 5, strain SH0165) (Cai et al. 2005) were grown in tryptic soy broth (TSB) (Difco, USA) or tryptic soy agar (TSA) (Difco, D r a f t 6 USA) supplemented with 10 µg/ml NAD (Sigma, St. Louis, MO) and 10% newborn calf serum (Gibco, USA). Escherichia coli was grown in Luria-Bertani (LB) broth or agar (Difco, USA) at 37 °C in the presence of 25 µg/mL kanamycin (Sigma, USA) when necessary. All bacterial strains were grown at 37 °C.
Purification of recombinant SOD protein
sodA gene was amplified by PCR using the following primers: sodAF (5'-GCGGATCCATGGCATACACATTAC-3'; underlined, BamHI site) and sodAR (5'-GCAAGCTTTTATGCTTGGGATTCA-3'; underlined, HindIII site). Then the PCR products were sub-cloned into the pET28a expression vector.
E. coli BL21 (DE3) (OD 600 =0.6) were induced with 1mM IPTG (Sigma, USA). A pilot experiment was performed and the molecular mass of the SOD protein was assessed by SDS-PAGE. The SOD protein was purified, as previously described with some minor modifications (Fu et al. 2013a) . Briefly, the cell pellet was suspended in 20 mL of buffer solution (50 mM Tris-HCl at pH 8.0, 500 mM NaCl and 1 mM PMSF) and disrupted in a French pressure cell. After centrifugation at 12,000 rpm for 20 min at 4 ℃, the supernatant was mixed with 5 mL of Ni 2+ -NTA agarose (Qiagen, Germany) in a column. Proteins not bound to Ni-NTA agarose were removed using 150 mL binding buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, and 5 mM imidazole following the first immunization. The blood samples were collected for immunologic assays by tail bleeding on day 14 after the booster immunization.
Determination of antibody titers
Serum for IgG titers against SOD protein was analyzed by enzyme linked immunosorbent assay (ELISA), as described previously (Fu et al. 2012b 
Lymphocyte proliferation
Lymphoproliferation assays were determined, as previously described with some minor modifications (Khan et al. 2006; Fu et al. 2013a ). Three mice from immunized group, the negative control group and the blank control group, were sacrificed on the 14th day following the boost immunization, and the spleens from the mice were isolated as recorded previously (Silva and Benitez 2005) . Briefly, spleens were in vitro and incubated for 72 h at 37 ℃ in a 5% CO 2 incubator. Lymphoproliferation assays were determined using
zolium (MTS) reagent with a cell proliferation kit (Promega, USA), according to the manufacturer's instructions. The lymphocytes were co-cultured in 96-well culture plates with MTS reagent for 4 h, and the absorbance was read at 490 nm wavelength using ELISA reader.
Determination of cytokines by ELISA
The supernatants from splenocytes cultures were collected after 72 h and stored at -80 ℃. The production of IL-2, IL-4, and IFN-γ from culture supernatants were measured using ELISA kits (R&D, USA), according to the manufacturer's instructions.
Whole blood killing bacteria assay
The bactericidal assay was determined as described previously (Furano and Campagnari 2003; Fu et al. 2013b) , with some minor modifications. Briefly, live bacteria of H. parasuis strain SH0165 or strain MD0322, were washed and diluted in sterile physiological saline. Samples of diluted bacteria (20 µL; 10 6 cells) were mixed with 180 µL inactivated test sera which were inactivated in a 56 ℃ water bath for half an hour diluted 2-fold with physiological saline, or diluted bacteria were mixed with saline alone. After incubation at 30 min under 37 ℃ and then 45 min on ice, nonimmune whole heparinized (10 U/mL) mouse blood (100 µL) was added, and the mixture was incubated at 37 ℃ with shaking for 1 h. Bacteria were then plated on TSA containing 10% newborn calf serum and 10 µg/mL NAD. Bacterial colony counts (CFU) were recorded after 36 h. Results were expressed as percent D r a f t killing according to the following formula: (CFU after 1 h of growth with control sera -CFU after 1 h of growth with immune sera)/CFU after 1 h of growth with control sera × 100. All assays were performed in triplicate and repeated three times.
Challenge experiments in mice
On day 14 following the booster immunization, mice immunized with SOD protein were randomly divided into groups 1 and 2 (15 mice/group) (immunized groups), mice immunized with Marcol 52 adjuvant were randomly divided into group 3 and 4 (15 mice/group) (negative control groups), mice immunized with PBS were randomly into 5 and 6 (15 mice/group) (blank control groups), respectively. Hence, the mice from groups 1, 3, and 5 were challenged intraperitoneally against a lethal dose of 6.0 × 10 9 CFU of H. parasuis SH0165 strain and the mice of groups 2, 4, and 6 were challenged intraperitoneally against a lethal dose of 6.0×10 9 CFU of H.
parasuis MD0322 infection, respectively. All mice were monitored regularly for 7 days following the challenge, and morbidity and mortality were recorded.
Histopathology
Lung tissues of mice from immunized group, negative control group and blank control group were fixed by immersion in 10% neutral buffered formalin and embedded in paraffin. And then 4 µm tissue sections were cut and stained with hematoxylin and eosin (H&E) according to a standard protocol and examined under light microscopy.
Passive immunization
Passive immunization experiments were conducted as previously described (Sun al. 2011; Fu et al. 2012b) . Briefly, the newly purchased 40 numbers four to five weeks old female BALB/c mice were randomly divided into four groups which were named groups 7-10. The groups 7 and 9 (ten mice per group) were intraperitoneally injected with 100 µL of serum from immunized mice and groups 8 and 10 (ten mice per group) were intraperitoneally injected with 100 µL of serum from adjuvant-immunized mice (negative group). At 24 h post-immunization, groups 7 and 8 were challenged against a lethal dose of 3.0 × 10 9 CFU of SH0165 strain of serovar 5, and groups 9 and 10 were challenged against a lethal dose of 3.0 × 10 9 CFU of MD0322 strain of serovar 4. All mice were monitored as described above and morbidity and mortality were recorded.
Statistical analysis
The experimental data were expressed as mean ± SD. The difference between two groups was analyzed using Student's t-test and the difference among three groups was analyzed using the ANOVA and survival analysis was used the Logrank test. p values of <0.05 were considered significant. *p < 0.05; **p < 0.01 and ***p < 0.001.
The results demonstrated that the mice immunized with the purified SOD protein exhibited significant antibody immune responses (p < 0.01) ( Fig. 2A) . However, the antibody production was not observed in mice from negative control group or blank control group (Fig. 2A) .
To further determine the type of immune response, the subclass of IgG1 and IgG2a were investigated. We showed that the levels of antibody isotypes were higher in the SOD-immunized group compared to the negative control group and blank control group (p < 0.001) (Fig. 2B) . Furthermore, IgG2a immune responses predominated over IgG1 immune responses (p < 0.01) (Fig. 2B ).
Determination of cytokine production
We showed that a significant proliferative T-cell immune response was displayed in the mice from immunized with SOD protein (p < 0.001) (Fig. 3A) . However, the blank control group and the negative control group could not induce a proliferative T-cell immune response (Fig. 3A) . In addition, a strong T cell proliferative response was elicited by concanavalin A (Con A) (p < 0.001) (Fig. 3A) .
The levels of IL-2 and IFN-γfrom the culture supernatants of splenocytes isolated from SOD-immunized group mice were significantly higher than that from the negative control group and the blank control group (p < 0.01) (Fig. 3B, 3C ). These results strongly suggested that immunization with SOD protein in mice could elicite a Th1-type immune response.
Mouse whole-blood killing bacteria assay
The results demonstrated that serum from the negative control group and the blank D r a f t 13 control group could not inhibit the growth of either SH0165 strain or MD0322 strain (Fig. 4) . However, the serum from SOD immunized group displayed a clearly reduction of the viable titers of SH0165 strain and MD0322 strain (p < 0.01) (Fig. 4) , which demonstrated that the antibodies induced by the recombinant SOD protein potentially provide a certain immunoprotection against the challenge of H. parasuis.
Protective efficacy against H. parasuis challenge in mice
The results of immunization and challenge experiments showed that the survival of mice from immunized with SOD protein against MD0322 strain challenge was significantly better than that group immunized with SOD protein against SH0165 strain challenge, 80% and 73.3%, respectively (p < 0.05) ( Fig. 5A and 5B). In addition, the immunoprotective efficacy in groups immunized with SOD protein were markedly greater compared with the blank control groups and the negative control groups (p < 0.01) (Fig. 5A) , in which no immunoprotective efficacy was observed, because all mice in the blank control group died within 2 days after challenge (Fig. 5B ).
The significance of antibody response to immunoprotection effect
The results showed that the percentages of surviving mice immunized with the serum from SOD protein against SH0165 strain or MD0322 strain challenge were 37.5% and 50%, respectively, which were significantly higher than that from the negative control group (p < 0.01) (Fig. 6A, 6B ).
Histopathologic analysis
All of the mice from the blank control groups and from the negative control groups displayed severe tissue damage in the lung. However, all survival mice from D r a f t 14 SOD protein immunized groups did not appear obvious pathological damage. Lung tissues from blank control groups or negative control groups challenged by either H.
parasuis MD0322 strain or SH0165 strain exhibited extensive edema with massive proliferation of fibroblasts and connective tissue formation. The bronchioles were suffused with cellular exudates composed of neutrophils (Fig. 7C, 7D, 7F, 7G ).
However, only minor pathological damages were detected in the tissue of lung from mice immunized with SOD protein (Fig. 7E, 7H ). These results indicated that immunization with SOD protein could inhibit tissue pathological damage following H.
parasuis challenge, which also confirm that SOD protein could confer immunoprotection efficacy against infection of H. parasuis.
Discussion
The current studies were carried out to explore the role of superoxide dismutase Previous studies have reported that SOD can control the levels of reactive oxygen species (ROS) and reduce neutrophil recruitment to the lung and dampen D r a f t inflammatory responses during noninfectious insult (Bowler et al. 2004; Yao et al. 2010) . Extracellular SOD has a high affinity in binding to heparin sulfate and collagen in the extracellular matrix (ECM) and has important effects on protecting tissues from oxidative damage and inflammation (Petersen et al. 2004; Gao et al. 2008 ).
Extracellular SOD also plays a detrimental effect during L. monocytogenes infection which decreased host survival, bacterial clearance, TNF-α and peroxynitrite production, and neutrophil function (Break et al. 2012) . SOD has been used in many It has been documented that serum resistance is thought to be an important virulence pathological mechanism in H. parasuis leading to pig systemic disease and virulent strain were mainly more resistant to the bactericidal effect of the serum than the non-virulent strains (Cerdà-Cuéllar and Aragon 2008). Serovars are commonly considered as a marker of virulence in H. parasuis (Oliveira and Pijoan 2004) . In general, serovar 5 was thought to be highly virulent, whereas serovar 4 was considered to be moderately virulent (Amano et al. 1994) . In this study, we elected to use the Chinese local isolates, MD0322 (serovar 4) strain and SH0165 (serovar 5) strain, as the challenge strains. These virulence strains allow us to simulate a natural situation of infection. In addition, we showed that both highly virulent SH0165 strain and moderately virulent MD0322 strain were killed by the antiserum induced by SOD protein with different degrees and serovar 4 MD0322 strain is more sensitive to bactericidal effect of the antiserum. This new finding is somehow contradictory to our previous finding (Fu et al. 2013a ). To address this discrepancy, we are in the process of designed new experiments to dissect the underlying mechanism. Furthermore, the immune blood serum. The results were performed from three independent assays. "*"
indicates significance at p < 0.05 and "**" indicates significance at p < 0.01. △, versus the negative control and the blank control. Survival of mice from SOD immunized group, negative control group and blank control group following challenge against H. parasuis SH0165 strain. group. Blood samples were collected on the 14 day after the booster immunization, and the antibody response was determined by ELISA; optical density readings of ＞ 0.3 were scored as positive. (B) The levels of IgG1 and IgG2a in mice from immunized group, the negative control group and the blank control group. Results are expressed as means ± SD. **, significance at a p value of < 0.01; ***, significance at a p value of < 0.001. △, versus the negative control group and the blank control group. black and white 98x49mm (300 x 300 DPI) D r a f t Fig.3. (A) Lymphocyte proliferation assay. On the 14th day following the boost immunization, 200 µL of splenocytes from immunized group, the negative control group and the blank control group were cultured (1 × 105 cells/mL) were stimulated with the SOD protein (4 µg/well) and concanavalin A (4 µg/well) and incubated for 72 h at 37 ℃ in a 5% CO2 incubator. (B) and (C) Levels of IL-2 and IFN-γ secretion in cultured splenocytes of mice from immunized group, the negative control group and the blank control group. Results are means ± SD; ***, significance at a p value of < 0.001. △, versus the negative control group and the blank control group. black and white 98x34mm (300 x 300 DPI) D r a f t Fig.4 . The whole blood bactericidal activity of SOD immunized, negative control and blank control mice. The results are expressed as the percent killing bacteria activity according to the percentage of reduction of bacteria growth in the presence of immune blood serum. The results were performed from three independent assays. "*" indicates significance at p < 0.05 and "**" indicates significance at p < 0.01. △, versus the negative control and the blank control. black and white 79x81mm (300 x 300 DPI) D r a f t 
